article thumbnail

5 Clinical Trial Myths Debunked

My Local Study

The misinformation surrounding clinical trials goes back decades and has a major impact on people’s willingness to volunteer. Many are hesitant to even consider a clinical trial because they don’t fully understand the process.

article thumbnail

Increasing trial participation for new cancer treatments

Elsevier

As one study put it: “The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies.”. And giving more patients access to trials certainly works to do that.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase

Pharma Mirror

This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

article thumbnail

Relmada sinks further as depression drug fails second large trial

Bio Pharma Dive

The company claimed an “unplausible” placebo response caused both studies to fail and is making substantive changes to its other remaining late-stage trial as a result

Trials 255
article thumbnail

Clinical trials face increasing challenges

Bio Pharma Dive

The COVID-19 pandemic emerged at a time when the clinical trial landscape had reached a peak in complexity. Global trials are now commonplace as drug makers seek to establish efficacy in diverse populations

article thumbnail

Reasons to Participate in a Clinical Trial in 2023

My Local Study

One of the most rewarding parts of participating in a clinical trial is that you are helping to advance medicine. Here are our top 8 reasons to participate in a clinical trial in 2023. The post Reasons to Participate in a Clinical Trial in 2023 appeared first on MyLocalStudy.com.

article thumbnail

What Biotech and Pharma need to consider about decentralized trials

Bio Pharma Dive

The pandemic motivated sponsors to reimagine decentralized trials and realize the benefits these models deliver

Trials 250
article thumbnail

Tackling barriers to diversity, equity, and inclusion in clinical trials

Clairnes

The post Tackling barriers to diversity, equity, and inclusion in clinical trials appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

Alnylam details anticipated results from heart disease drug trial

Bio Pharma Dive

Fuller data from Alnylam’s APOLLO-B trial confirm the success reported by the company last month, but won’t end a debate on the degree of benefit offered by its drug

article thumbnail

JPM23: Vaccine developers as dealmakers, Gilead’s trial tea leaves and building platform companies

Bio Pharma Dive

Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial

article thumbnail

A unified, connected foundation is transforming the future of digital trials

Bio Pharma Dive

A holistic approach allows stakeholders to adapt to the ever-increasing number of clinical trials and data points

article thumbnail

Accelerating virtual clinical trials

Bio Pharma Dive

Leveraging the guidance and support of trial virtualization professionals with experience in key areas of a trial's lifecycle will undoubtedly impact overall success

article thumbnail

Practical approaches to operationalizing decentralized clinical trials

Bio Pharma Dive

When appropriate, DCTs can accelerate trial conduct, create a wealth of high-quality data and improve efficiency

article thumbnail

We must improve diversity in clinical trials. These 5 steps will help.

Bio Pharma Dive

The pandemic shined a light on the importance of diversity in clinical trials. Syneos Health can help your team devise a diversity strategy

article thumbnail

De-risking oncology trials with medical monitoring

Bio Pharma Dive

Phase three oncology studies have approximately a 35% likelihood of leading to regulatory approval

Trials 274
article thumbnail

New cancer drug clinical trials struggling

World of DTC Marketing

WHAT’S THIS ABOUT THEN : Researchers are rushing to launch clinical trials of experimental vaccines against the coronavirus, and treatments for COVID-19. Eli Lilly recently announced that it would halt enrolment in ongoing studies and delay the launch of new trials.

article thumbnail

Allogene starts first pivotal trials of an ‘off-the-shelf’ cell therapy for cancer

Bio Pharma Dive

The biotech believes the two Phase 2 trials initiated Thursday can support approval applications for what could be the first so-called allogeneic cancer cell therapy

Trials 261
article thumbnail

Roche, nearing major trial readouts, starts new Alzheimer's drug study

Bio Pharma Dive

A large, multi-year trial is part of that bet As Aduhelm sputters on the market, Roche aims to prove its experimental medicine can work better.

Trials 252
article thumbnail

Breaking down the barriers to decentralized trials

Bio Pharma Dive

Decentralized trials are here to stay. Here's how technology has and will continue to pave the way

Trials 236
article thumbnail

GSK sets high bar with trial results for RSV vaccine

Bio Pharma Dive

With data expected for several other vaccines for the respiratory disease, GSK reported positive clinical trial results showing efficacy above 80

article thumbnail

How to address patient privacy and data-security concerns in clinical trials

Clairnes

The post How to address patient privacy and data-security concerns in clinical trials appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

Why are clinical trials struggling with diversity?

Pharma Phorum

Racial disparities are still commonplace in many clinical trials with white-ethnic groups often overrepresented amongst trial participants. While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go.

article thumbnail

Questions Frequently Asked Pertaining to Clinical Trials

Riverside Clinical Research

If you are considering playing a vital role in the advancement of medicine and medical technology by embarking on your first experience as a clinical trial volunteer, you most likely have a few questions about clinical research and the clinical trial process.

article thumbnail

Accelerating patient care through digital transformation and decentralized clinical trials

Bio Pharma Dive

The adoption of digital health technologies (DHTs) in the industry continues to pave the way to enable decentralized clinical trials (DCTs

article thumbnail

Clinical trials: 2021 Recap and take-aways for 2022 and ahead. From Vaccine trials, new regulations, decentralized trials and patient-centricity

Clairnes

The post Clinical trials: 2021 Recap and take-aways for 2022 and ahead. From Vaccine trials, new regulations, decentralized trials and patient-centricity appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

J&J, Legend’s cancer cell therapy has early success in key clinical trial

Bio Pharma Dive

The trial is an important test of Carvykti’s potential for earlier use in multiple myeloma and found treatment helped extend progression-free survival over standard regimens

article thumbnail

Clinical trial DTC? It may not be right for your drug candidate

World of DTC Marketing

SUMMARY: Over half of all clinical trial sites are outside the U.S. 87 % of all subjects in recent biologics trials were enrolled outside the U.S. DTC may or may not work for clinical trial enrollment it really depends on the condition and risk as judged by the patient.

article thumbnail

Patient-Centered Clinical Trials: Tips for Sites

Crucial Data Soutions

More patient-centered study designs are key to improving recruitment, retention, and keeping patients engaged over the course of a trial, factors that should combine to deliver higher quality safety and efficacy data more quickly.

article thumbnail

Amgen to test new way to lower heart risk with large drug trial

Bio Pharma Dive

Buoyed by strong mid-stage study results, the biotech will soon start a cardiovascular outcomes trial of a drug designed to target a genetic risk factor called lipoprotein(a

article thumbnail

4 Benefits Of Clinical Trial Participation

Olympian Clinical Research

Clinical trials are research studies designed to evaluate or test a medical, surgical, or behavioral intervention. Most recently, clinical trials have gained recognition through the development and testing of Covid-19 vaccines.

article thumbnail

MEI, Kyowa stop lymphoma drug trials after FDA meeting

Bio Pharma Dive

The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors

article thumbnail

The right way to use social media for clinical trial recruitment

Clairnes

The post The right way to use social media for clinical trial recruitment appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

How digital patient recruitment can reduce enrollment costs in Major Depressive Disorder clinical trials

Clairnes

The post How digital patient recruitment can reduce enrollment costs in Major Depressive Disorder clinical trials appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

Maximizing patient recruitment for rhinosinusitis trials in a competitive market

Clairnes

The post Maximizing patient recruitment for rhinosinusitis trials in a competitive market appeared first on Clinical Trial Recruitment & Management Services.

article thumbnail

Merck terminates Lynparza trial in colorectal cancer

Bio Pharma Dive

The setback slows plans to broaden use of a drug that analysts expect to generate nearly $10 billion in annual sales later this decade

Sales 224
article thumbnail

Pfizer gene therapy research delayed by trial changes, safety questions

Bio Pharma Dive

Data readouts for Pfizer's hemophilia gene therapies are now expected later than previously forecast, while the company also works through modifying a trial of its Duchenne treatment

article thumbnail

Oncology Clinical Trials: Considerations and Challenges

XTalks

While clinical trials are becoming more complex, oncology trials have generally had a greater level of complexity than trials in many other disease spaces. Despite this, the number of oncology trials worldwide has increased dramatically over the past two decades.

article thumbnail

Novavax details trial results for omicron-targeting booster shots

Bio Pharma Dive

A reformulated booster aimed at an earlier omicron subvariant outperformed Novavax’s current vaccine, but a bivalent version did not significantly raise antibody levels

Antibody 258
article thumbnail

BioMarin reports cancer case in hemophilia gene therapy trial

Bio Pharma Dive

Drug regulators have not ordered a trial hold, however The development comes three weeks after Roctavian was approved in Europe and ahead of a planned regulatory submission in the U.S.

article thumbnail

Patient-Centricity and Decentralized Clinical Trials

Crucial Data Soutions

Despite the rise in utilization of decentralized clinical trial (DCT) elements, there are still many misconceptions. Who wouldn’t prefer to take part in a clinical trial from the comfort of their homes?

article thumbnail

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

Pharma Phorum

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations.

Trials 83
article thumbnail

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Pharma Mirror

The post Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China appeared first on Pharma Mirror Magazine. Pharmaceutical News Oncology Clinical Trials

article thumbnail

Pandemic boost to decentralised trials is here to stay

Pharma Phorum

Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element of drug development. Ben Hargreaves examines the latest research suggesting that this transition looks set to become a permanent feature of trials in the years to come.

Trials 94